Back to top

CMMB Stock: Oppenheimer Analyst Raises Price Target to $25 | CMMB Stock News

CMMB Stock: Oppenheimer Analyst Raises Price Target to $25 | CMMB Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Chemomab Therapeutics Ltd. Sponsored ADR (CMMB)